Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I
Por:
Ramos, D, Francesqui, J, Bollo, E, Villar, A, Florez, P, Balcells, E, Castaño, G, Pinillos-Robles, EJ, Godoy-Mayoral, R, Lopez-Muñiz, B, Soler-Sampere, MJ, Castillo, D, Rafecas-Codern, A, Mariscal-Aguilar, P, Portillo, K, Gomez-Carrera, L, Bonilla, G, Millan-Billi, P, Hernández-González, F and Sellarés, J
Publicada:
1 ene 2026
Ahead of Print:
1 dic 2025
Resumen:
Background: Sarcoidosis is a multi-organ granulomatous disease with a variable course. To predict mortality in routine clinical practice is challenging, thus, it is imperative to identify predictors of mortality in pulmonary sarcoidosis to guide therapy and management effectively. This study aims to evaluate predictors of all-cause mortality at 5 years in patients with pulmonary sarcoidosis from a Spanish cohort. Study design: We developed a retrospective, multicentre analysis from the Spanish pulmonary sarcoidosis cohort (SARCO-I), which included 765 patients diagnosed according to 1999 WASOG criteria. Demographic, clinical, radiological, functional, and laboratory characteristics were analysed. Composite physiological index (CPI) at diagnosis and functional and imaging progression according to the progressive pulmonary fibrosis (PPF) criteria, were also assessed. Univariate and multivariate analyses were performed using Cox proportional hazards models to evaluate predictors of 5-year all-cause mortality. Results: At 5 years from diagnosis, 43 (5.6 %) deaths were reported. Upon multivariate analysis, age at diagnosis and baseline CPI emerged as independent predictors of mortality at 5 years. The age threshold of over 50 years (HR 21.16, CI 95 % 2.75-162) and a CPI >35 (HR 2.84, CI 95 % 1.06-7.6) demonstrated the best discrimination of mortality. The presence of fibrosis at diagnosis, functional deterioration, and radiological progression within the first year did not emerge as predictors of mortality. Conclusion: Age over 50 years and a CPI greater than 35 were identified as independent predictors of 5-year allcause mortality in our Spanish pulmonary sarcoidosis cohort.
Filiaciones:
Ramos, D:
Inst Nacl Torax, Santiago, Chile
Francesqui, J:
Hosp Santa Creu & Sant Pau, IR ST PAU, Barcelona, Spain
Hosp Clin Barcelona, Barcelona, Spain
Bollo, E:
Complejo Asistencial Univ Leon, Leon, Spain
Villar, A:
Hosp Valle De Hebron, Barcelona, Spain
Florez, P:
Hosp Univ Principe Asturias, Madrid, Spain
Balcells, E:
Hosp del Mar IMIM, Dept Neumol, Barcelona, Spain
Univ Pompeu Fabra UPF, Dept Med & Ciencias Vida MELIS, Barcelona, Spain
Castaño, G:
Hosp Jarrio, Asturias, Spain
Pinillos-Robles, EJ:
Hosp Univ Fundacio Jimenez Diaz, Madrid, Spain
Godoy-Mayoral, R:
Complejo Hosp Univ Albacete, Albacete, Spain
Lopez-Muñiz, B:
Hosp Infanta Leonor, Madrid, Spain
Soler-Sampere, MJ:
Hosp Gen Univ Elche, Alicante, Spain
Castillo, D:
Hosp Santa Creu & Sant Pau, IR ST PAU, Barcelona, Spain
Rafecas-Codern, A:
Hosp Santa Creu & Sant Pau, IR ST PAU, Barcelona, Spain
Mariscal-Aguilar, P:
Hosp Univ La Paz, Madrid, Spain
:
Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
Gomez-Carrera, L:
Hosp Univ La Paz, Madrid, Spain
Bonilla, G:
Hosp Univ La Paz, Madrid, Spain
:
Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
Hernández-González, F:
Hosp Clin Barcelona, Barcelona, Spain
Sellarés, J:
Hosp Clin Barcelona, Barcelona, Spain
|